Expanding access to mpox testing

Mpox is an ongoing global health challenge, with continued cases in endemic countries and the offshoot of the clade I variant, clade Ib. An effective public health response to mpox requires coordinated action – surveillance, diagnostics, risk communication and community engagement.

We believe everyone should have access to fast, reliable testing. As a leader in molecular technologies, we’re focused on providing continued access to testing and surveillance solutions.